skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I was looking for companies that manufacture municipal water pipes. This is the only publicly traded, pure-play company I could find (there are others in the water infrastructure space that make valves, smaller drainage pipes, hydrants, software, etc.). Are you aware of any other companies that focus on the large water-carrying pipes? And what are your thoughts of this company as a long term investment? Its historical chart is a bit rocky but it's up 60% over the last year? Does it still have some room to grow?
Read Answer Asked by Brendan on October 24, 2024
Q: Peter and His Wonder Team
I am not a gold bug but I can see the reasons why it is over $2700.00 and heading for $3000.00. I have owned this company forever and am almost even. I know it is small and will move in tandem with gold. Do you think it has any potential to go a little higher or is the price of gold already baked in. So is it a hold or sell? Thanks!
Read Answer Asked by Ernest on October 23, 2024
Q: Hi team;
Any reason for the weakness in Canadian names today ? Namely the mentioned names for example, especially Gsy? Gsy down 10% in 2 days seems a bit drastic. Is there concern here or a bit the dip opportunity?

Thanks ,
Shane
Read Answer Asked by Shane on October 22, 2024
Q: AEYE Your thoughts on this company. Is it a Buy, hold or sell? Thanks
Read Answer Asked by Charles on October 22, 2024
Q: Peter and His Wonder Team
Of course I am a long time holder of this company and a down a ton. Do you think this company has any ability to advance? I am down so much it seems better to wait if it has any chance to progress. In other words I have a lot more to gain than lose by waiting...if you know what I mean. On the other hand I know we have to accept our losses. Thanks for your opinion!
Read Answer Asked by Ernest on October 21, 2024
Q: Hi,

Can you please confirm the FY24 and FY25 consensus EPS as seen on your Key Ratios company page for WELL. It seems the EPS is forecast to drop approx 40%.... .17 cents vs .12 cents respectively which does not seem very enticing. Although many of the other key ratios do look attractive so I wonder what is keeping this stock from performing better?
I have owned WELL for awhile now (marginally ahead) but my patience is growing thin and was thinking of splitting some of the proceeds (if I sell) towards Vitalhub and/or Kneat (which are both now close to their 52 week highs vs WELL) as part of my small cap health exposure. I took part in a DKAM update yesterday and they have VHI and KSI as part of their top 10 stocks for 2025 and I have followed some of their recommendations for years and done very well.
Just curious what your favourite is of these 3 health stocks. In the past you have suggested all 3 as favourable at various times but I know acquisitions etc can move some stocks ahead of others and all have made recent headlines.

Cheers,
SMc
Read Answer Asked by Stephen on October 21, 2024
Q: I've been considering buying TVK for some time. One of the things holding me back is the potential of a Trump victory and the subsequent imposition of 20% across the board import tarrifs. Given the resource industries that TVK supports, what impact on share price would you predict such tarrifs would have? Would you suggest prospective buyers of TVK wait until after the election to wade in?
Read Answer Asked by Maureen on October 21, 2024
Q: I heard NVDA have invested in below 5 stocks
ARM, NNOX, RXRX, SOUN & TSPH.

Can you please confirm if they really have and would you consider as a buy and why.

If yes in which order would you purchase.

Please deduct credit as required

Thanks for your great service
Read Answer Asked by Hector on October 18, 2024
Q: In June this year you named this company as one of your favorite cyclicals. I didn't buy it but it has dropped significantly since then. I am considering buying it now as it looks like EPS has exceeded expectations for at least the last 4 Q's. Would you still consider it a buy or have fundamentals changed? Thank you. John
Read Answer Asked by John on October 17, 2024
Q: Just finished reading both questions and your report on CPH ..... I don't see any resemblance between your report and the current company .... Could you give me the " Cole's Notes " review of the state of the current company ? What's positive in the pipeline ? What's negative ? I see the failure of the nail fungus drug initially dropped the stock $5 but it has recovered since. Does that mean the drug is not dead ? Thanks for your terrific service ..... { any plans to update that report ? }
Read Answer Asked by Garth on October 17, 2024